Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease

Aim. This work was to study activation markers of apoptosis (CD95, CD95L) on peripheral blood lymphocytes of patients with type 1 diabetes mellitus (DM1) at the onset of the disease. Materials and methods. A total of 33 patients (25 men and 8 women) divided into 2 groups were available for biochem...

Full description

Bibliographic Details
Main Authors: Elena Vladimirovna Pekareva, Tatiana Vasil'evna Nikonova, Vera Anatol'evna Gorelysheva, Yana Stanislavovna Zvereva, Svetlana Mikhailovna Stepanova, Sergey Alexandrovich Prokof'ev, Olga Mikhailovna Smirnova
Format: Article
Language:English
Published: Endocrinology Research Centre 2009-12-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/5711
_version_ 1797255305010085888
author Elena Vladimirovna Pekareva
Tatiana Vasil'evna Nikonova
Vera Anatol'evna Gorelysheva
Yana Stanislavovna Zvereva
Svetlana Mikhailovna Stepanova
Sergey Alexandrovich Prokof'ev
Olga Mikhailovna Smirnova
author_facet Elena Vladimirovna Pekareva
Tatiana Vasil'evna Nikonova
Vera Anatol'evna Gorelysheva
Yana Stanislavovna Zvereva
Svetlana Mikhailovna Stepanova
Sergey Alexandrovich Prokof'ev
Olga Mikhailovna Smirnova
author_sort Elena Vladimirovna Pekareva
collection DOAJ
description Aim. This work was to study activation markers of apoptosis (CD95, CD95L) on peripheral blood lymphocytes of patients with type 1 diabetes mellitus (DM1) at the onset of the disease. Materials and methods. A total of 33 patients (25 men and 8 women) divided into 2 groups were available for biochemical, genetic, and immunological examination. Results. Those with the ?classical? onset of DM1 had significantly fewer CD95-expressing lymphocytes and more CD95L+ lymphocytes than control subjects. Carriers of genes responsible for high risk of DM1 showed especially large number of lymphocytes expressing CD95L. Conclusion. It is conjectured that DM1 is characterized by the suppression of mechanism controlling apoptosis of activated lymphocytes that may promote prolongation of the immune response.
first_indexed 2024-03-08T15:22:41Z
format Article
id doaj.art-c2715a984cfc45a0a704c028f45ac9aa
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:03:44Z
publishDate 2009-12-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-c2715a984cfc45a0a704c028f45ac9aa2024-03-20T11:47:55ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782009-12-01124738910.14341/2072-0351-57115669Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the diseaseElena Vladimirovna Pekareva0Tatiana Vasil'evna Nikonova1Vera Anatol'evna Gorelysheva2Yana Stanislavovna Zvereva3Svetlana Mikhailovna Stepanova4Sergey Alexandrovich Prokof'ev5Olga Mikhailovna Smirnova6Endocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowAim. This work was to study activation markers of apoptosis (CD95, CD95L) on peripheral blood lymphocytes of patients with type 1 diabetes mellitus (DM1) at the onset of the disease. Materials and methods. A total of 33 patients (25 men and 8 women) divided into 2 groups were available for biochemical, genetic, and immunological examination. Results. Those with the ?classical? onset of DM1 had significantly fewer CD95-expressing lymphocytes and more CD95L+ lymphocytes than control subjects. Carriers of genes responsible for high risk of DM1 showed especially large number of lymphocytes expressing CD95L. Conclusion. It is conjectured that DM1 is characterized by the suppression of mechanism controlling apoptosis of activated lymphocytes that may promote prolongation of the immune response.https://www.dia-endojournals.ru/jour/article/view/5711type 1 diabetes mellitusapoptosiscd95cd95lcd95cd95l
spellingShingle Elena Vladimirovna Pekareva
Tatiana Vasil'evna Nikonova
Vera Anatol'evna Gorelysheva
Yana Stanislavovna Zvereva
Svetlana Mikhailovna Stepanova
Sergey Alexandrovich Prokof'ev
Olga Mikhailovna Smirnova
Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease
Сахарный диабет
type 1 diabetes mellitus
apoptosis
cd95
cd95l
cd95
cd95l
title Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease
title_full Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease
title_fullStr Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease
title_full_unstemmed Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease
title_short Markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease
title_sort markers of apoptosis in patients with type 1 diabetes mellitus at the onset of the disease
topic type 1 diabetes mellitus
apoptosis
cd95
cd95l
cd95
cd95l
url https://www.dia-endojournals.ru/jour/article/view/5711
work_keys_str_mv AT elenavladimirovnapekareva markersofapoptosisinpatientswithtype1diabetesmellitusattheonsetofthedisease
AT tatianavasilevnanikonova markersofapoptosisinpatientswithtype1diabetesmellitusattheonsetofthedisease
AT veraanatolevnagorelysheva markersofapoptosisinpatientswithtype1diabetesmellitusattheonsetofthedisease
AT yanastanislavovnazvereva markersofapoptosisinpatientswithtype1diabetesmellitusattheonsetofthedisease
AT svetlanamikhailovnastepanova markersofapoptosisinpatientswithtype1diabetesmellitusattheonsetofthedisease
AT sergeyalexandrovichprokofev markersofapoptosisinpatientswithtype1diabetesmellitusattheonsetofthedisease
AT olgamikhailovnasmirnova markersofapoptosisinpatientswithtype1diabetesmellitusattheonsetofthedisease